Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

May 22, 2024

Study Completion Date

May 23, 2024

Conditions
Neuropathy;PeripheralChemotherapy-induced Peripheral NeuropathyNeuropathy
Interventions
DEVICE

Voxx Human Performance Technology Socks

"Voxx Human Performance Technology Socks are commercially-available socks that are drug and electrical free. The Voxx Human Performance Technology proprietary pattern is woven into a sock that is made of 70% cotton, 25% polyester, 3% spandex, and 2% nylon.~Prior to the 2-week treatment window, patients will be provided with 6 pairs of Voxx Human Performance Technology socks. Patients will be asked to wear the socks continuously during both waking and sleeping hours, except when showering, bathing, or swimming."

DEVICE

Placebo Socks

"Placebo socks are identical to the Voxx Human Performance Technology socks but do not include the Voxx Human Performance Technology pattern woven into the sock. Placebo socks are made of the same fabric as Voxx Human Performance Technology socks and are drug and electrical free.~Prior to the 2-week treatment window, patients will be provided with 6 pairs of placebo socks. Patients will be asked to wear the socks continuously during both waking and sleeping hours, except when showering, bathing, or swimming."

Trial Locations (2)

90048

Cedars Sinai Medical Center, Los Angeles

90505

CS Cancer at the Hunt Cancer Center, Torrance

All Listed Sponsors
collaborator

VoxxLife

UNKNOWN

lead

Arash Asher, MD

OTHER

NCT04403802 - Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy | Biotech Hunter | Biotech Hunter